Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» gene editing
gene editing
How CRISPR can help us win the fight against the pandemic
MedCity News
Tue, 05/12/20 - 10:10 pm
CRISPR
gene editing
pandemic
COVID-19
R&D
Sangamo Therapeutics and Biogen Announce Gene-Therapy Deal, Stock up 39%
Motley Fool
Thu, 02/27/20 - 11:43 pm
Sangamo Therapeutics
Biogen
gene therapy
gene editing
Parkinson's Disease
Alzheimer's disease
FDA Clinical Hold Stops LogicBio’s Gene Editing Study Before It Starts
Xconomy
Mon, 02/10/20 - 11:25 pm
LogicBio Therapeutics
gene editing
clinical trials
methylmalonic acidemia
FDA
Beam Therapeutics IPO Raises $180M After Nearly Doubling Shares Offered
Xconomy
Thu, 02/6/20 - 11:49 pm
IPOs
Beam Therapeutics
gene editing
This Start-up Might Be the Next Gene Editing IPO
Motley Fool
Thu, 12/19/19 - 12:50 pm
gene editing
Beam Therapeutics
IPOs
CRISPR
Celgene Gave This Tech Back to Editas Medicine, but It Could Prove Valuable
Motley Fool
Thu, 12/5/19 - 11:32 pm
Celgene
Editas Medicine
Juno Therapeutics
CRISPR
gene editing
More CRISPR Stock Catalysts Ahead
Motley Fool
Mon, 11/25/19 - 09:38 am
gene editing
CRISPR
Editas Medicine
Intellia Therapeutics
CRISPR Therapeutics
Cellectis gene editing patent upheld in Europe
Seeking Alpha
Thu, 11/21/19 - 10:31 am
gene editing
Europe
Cellectis
patents
Biotech Stock Pops On Promising First In-Human CRISPR Gene-Editing Drug
Investors Business Daily
Wed, 11/20/19 - 09:53 am
CRISPR Therapeutics
gene editing
CRISPR
beta thalassemia
sickle cell disease
Editas and Celgene sub Juno are tackling hottest immunotherapy cells
Endpoints
Tue, 11/12/19 - 08:07 pm
Editas Medicine
Celgene
Juno Therapeutics
CRISPR
gene editing
immunotherapy
A Look at America’s First CRISPR Clinical Trial
Xtalks
Mon, 11/11/19 - 10:59 am
CRISPR
gene editing
clinical trials
First use of CRISPR against cancer in patients clears early safety hurdles
Stat
Wed, 11/6/19 - 10:36 am
gene editing
CRISPR
patient safety
cancer
A deal-hungry Vertex ushers in three more gene editing programs as it closes out harbinger CRISPR deal
Endpoints
Mon, 10/28/19 - 10:54 am
Vertex Pharmaceuticals
CRISPR
gene editing
CTX001
Why Novo Nordisk should buy Uniqure
EP Vantage
Fri, 10/11/19 - 10:31 am
Novo Nordisk
gene editing
hemophilia
uniQure
Bluebird Bio
Novo taps bluebird bio for gene-editing tech
Fierce Biotech
Wed, 10/9/19 - 09:43 am
Novo Nordisk
Bluebird Bio
R&D
gene editing
hemophilia
3 Reasons Vertex Pharmaceuticals Is Poised for a Big Year
Motley Fool
Tue, 10/8/19 - 10:21 am
Vertex Pharmaceuticals
cystic fibrosis
gene editing
Gene-Editing Company Beam Seeks $100 Million IPO
BioSpace
Mon, 09/30/19 - 11:40 pm
Beam Therapeutics
IPOs
gene editing
Can Synthetic Biology Make Insulin Faster, Better and Cheaper?
Forbes
Sat, 09/21/19 - 12:39 pm
diabetes
insulin
drug pricing
Genentech
gene editing
CRISPR Gene-Editing May Offer Path To Cure For HIV, First Published Report Shows
NPR
Wed, 09/11/19 - 11:42 pm
HIV
CRISPR
gene editing
Challenging CRISPR, Trucode Raises $34M for New Gene-Editing System
Xconomy
Tue, 09/10/19 - 10:39 am
Trucode
gene editing
CRISPR
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
next ›
last »